Erratum: The anti-angiogenic herbal composition Ob-X inhibits adipose tissue growth in obese mice (International Journal of Obesity (2010) DOI: 10.1038/ijo.2010.13);The anti-angiogenic herbal composition Ob-X inhibits adipose tissue growth in obese mice

International Journal of Obesity

Volumn 34, Issue 5, 2010, Pages 820-830

  Kim, M Y ^a   Park, B Y ^a   Lee, H S ^a   Park, E K ^a   Hahm, J C ^a   Lee, J ^b   Hong, Y ^b   Choi, S ^b   Park, D ^b   Lee, H ^b   Yoon, M ^b  

^a AngioLab Inc   (South Korea)

^b Mokwon University   (South Korea)

Author keywords

Abdominal fat; Adipose tissue growth; Angiogenesis; Inhibition; MMP

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; GELATINASE A; GELATINASE B; HERBACEOUS AGENT; MATRIX METALLOPROTEINASE; MESSENGER RNA; OB X INHIBITOR; THROMBOSPONDIN 1; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; UNCLASSIFIED DRUG; VASCULOTROPIN A; ANGIOGENESIS INHIBITOR; MATRIX METALLOPROTEINASE INHIBITOR; PLANT EXTRACT;

ABDOMINAL SUBCUTANEOUS FAT; ADIPOCYTE; ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIANGIOGENIC ACTIVITY; ARTICLE; BLOOD VESSEL; CELL SIZE; COMPARATIVE STUDY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME REPRESSION; EX VIVO STUDY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; IN VITRO STUDY; INTRAABDOMINAL FAT; LIPID DIET; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OBESITY; PRIORITY JOURNAL; RAT; TISSUE GROWTH; UMBILICAL VEIN; VASCULAR RING; WEIGHT GAIN; ANIMAL; CYTOLOGY; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; IMMUNOBLOTTING; MELISSA OFFICINALIS; MORUS; MOUSE MUTANT; PHYTOTHERAPY; PROCEDURES; VASCULARIZATION;

MUS; RATTUS;

ADIPOCYTES; ADIPOSE TISSUE; ANGIOGENESIS INHIBITORS; ANIMALS; IMMUNOBLOTTING; MATRIX METALLOPROTEINASE INHIBITORS; MELISSA; MICE; MICE, OBESE; MORUS; PHYTOTHERAPY; PLANT EXTRACTS; RATS;

EID: 77952289302     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2010.68     Document Type: Erratum

References (48)

1. Couillard C, Mauriège P, Imbeault P, Prud'homme D, Nadeau A, Tremblay A et al. Hyperleptinemia is more closely associated with adipose cell hypertrophy than with adipose tissue hyperplasia. Int J Obes Relat Metab Disord 2000; 24: 782-788.
2. Crandall DL, Hausman GJ, Kral JG. A review of the microcircula-tion of adipose tissue: anatomic, metabolic, and angiogenic perspectives. Microcirculation 1997; 4: 211-232.
3. Hobson B, Denekamp J. Endothelial proliferation in tumours and normal tissues: continuous labelling studies. Br J Cancer 1984; 49: 405-413.
4. Bouloumié A, Lolmède K, Sengenès C, Galitzky J, Lafontan M. Angiogenesis in adipose tissue. Ann Endocrinol (Paris) 2002; 63: 91-95.
5. Silverman KJ, Lund DP, Zetter BR, Lainey LL, Shahood JA, Freiman DG et al. Angiogenic activity of adipose tissue. Biochem Biophys Res Commun 1988; 153: 347-352.
6. Rupnick MA, Panigrahy D, Zhang C, Dallabrida SM, Lowell BB, Langer R et al. Adipose tissue mass can be regulated through the vasculature. Proc Natl Acad Sci USA 2002; 99: 10730-10735.
7. Bra°kenhielm E, Cao R, Gao B, Angelin B, Cannon B, Parini P et al. Angiogenesis inhibitor, TNP-470, prevents diet-induced and genetic obesity in mice. Circ Res 2004; 94: 1579-1588.
8. Neels JG, Thinnes T, Loskutoff DJ. Angiogenesis in an in vivo model of adipose tissue development. FASEB J 2004; 18: 983-985.
9. Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 2003; 92: 827-839.
10. Lijnen HR, Maquoi E, Hansen LB, Van Hoef B, Frederix L, Collen D. Matrix metalloproteinase inhibition impairs adipose tissue development in mice. Arterioscler Thromb Vasc Biol 2002; 22: 374-379.
11. Galardy RE, Grobelny D, Foellmer HG, Fernandez LA. Inhibition of angiogenesis by the matrix metalloprotease inhibitor N-[2R-2- (hydroxamidocarbonymethyl)-4-methylpentanoyl)]-L-trypto-phan methylamide. Cancer Res 1994; 54: 4715-4718.
12. Bouloumié A, Sengenès C, Portolan G, Galitzky J, Lafontan M. Adipocyte produces matrix metalloproteinases 2 and 9: involvement in adipose differentiation. Diabetes 2001; 50: 2080-2086.
13. Kawaguchi N, Toriyama K, Nicodemou-Lena E, Inou K, Torii S, Kitagawa Y. De novo adipogenesis in mice at the site of injection of basement membrane and basic fibroblast growth factor. Proc Natl Acad Sci USA 1998; 95: 1062-1066.
14. Christiaens V, Lijnen HR. Role of the fibrinolytic and matrix metalloproteinase systems in development of adipose tissue. Arch Physiol Biochem 2006; 112: 254-259.
15. Chavey C, Mari B, Monthouel MN, Bonnafous S, Anglard P, Van Obberghen E et al. Matrix metalloproteinases are differentially expressed in adipose tissue during obesity and modulate adipocyte differentiation. J Biol Chem 2003; 278: 11888-11896.
16. Maquoi E, Munaut C, Colige A, Collen D, Lijnen HR. Modulation of adipose tissue expression of murine matrix metalloproteinases and their tissue inhibitors with obesity. Diabetes 2002; 51: 1093-1101.
17. Lijnen HR, Maquoi E, Holvoet P, Mertens A, Lupu F, Morange P et al. Adipose tissue expression of gelatinases in mouse models of obesity. Thromb Haemost 2001; 85: 1111-1116.
18. Lijnen HR, Maquoi E, Hansen LB, Van Hoef B, Frederix L, Collen D. Matrix metalloproteinase inhibition impairs adipose tissue development in mice. Arterioscler Thromb Vasc Biol 2002; 22: 374-379.
19. Voros G, Maquoi E, Demeulemeester D, Clerx N, Collen D, Lijnen HR. Modulation of angiogenesis during adipose tissue development in murine models of obesity. Endocrinology 2005; 146: 4545-4554.
20. Cao Y. Angiogenesis modulates adipogenesis and obesity. J Clin Invest 2007; 117: 2362-2368.
21. Claffey KP, Wilkison WO, Spiegelman BM. Vascular endothelial growth factor. Regulation by cell differentiation and activated second messenger pathways. J Biol Chem 1992; 267: 16317-16322.
22. Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 1996; 380: 435-439.
23. Bikfalvi A, Klein S, Pintucci G, Rifkin DB. Biological roles of fibroblast growth factor-2. Endocr Rev 1997; 18: 26-45.
24. Kawaguchi N, Toriyama K, Nicodemou-Lena E, Inou K, Torii S, Kitagawa Y. De novo adipogenesis in mice at the site of injection of basement membrane and basic fibroblast growth factor. Proc Natl Acad Sci USA 1998; 95: 1062-1066.
25. Sang QX. Complex role of matrix metalloproteinases in angio-genesis. Cell Res 1998; 8: 171-177.
26. Lee J, Chae K, Ha J, Park BY, Lee HS, Jeong S et al. Regulation of obesity and lipid disorders by herbal extracts from Morus alba, Melissa officinalis, and Artemisia capillaris in high-fat diet-induced obese mice. J Ethnopharmacol 2008; 115: 263-270.
27. Krüger EA, Figg WD. Protein binding alters the activity of suramin, carboxyamidotriazole, and UCN-01 in an ex vivo rat aortic ring angiogenesis assay. Clin Cancer Res 2001; 7: 1867-1872.
28. Nicosia RF, Bonanno E, Villaschi S. Large-vessel endothelium switches to a microvascular phenotype during angiogenesis in collagen gel culture of rat aorta. Atherosclerosis 1992; 95: 191-199.
29. Liu L, Meydani M. Angiogenesis inhibitors may regulate adiposity. Nutr Rev 2003; 61: 384-387.
30. Pierleoni C, Verdenelli F, Castellucci M, Cinti S. Fibronectins and basal lamina molecules expression in human subcutaneous white adipose tissue. Eur J Histochem 1998; 42: 183-188.
31. Sadowski T, Dietrich S, Koschinsky F, Sedlacek R. Matrix metalloproteinase 19 regulates insulin-like growth factor-mediated proliferation, migration, and adhesion in human keratinocytes through proteolysis of insulin-like growth factor binding protein-3. Mol Biol Cell 2003; 14: 4569-4580.
32. Lijnen HR. Angiogenesis and obesity. Cardiovasc Res 2008; 78: 286-293.
33. Arner P. Regional differences in protein production by human adipose tissue. Biochem Soc Trans 2001; 29: 72-75.
34. Park HY, Kwon HM, Lim HJ, Hong BK, Lee JY, Park BE et al. Potential role of leptin in angiogenesis: leptin induces endothe-lial cell proliferation and expression of matrix metalloproteinases in vivo and in vitro. Exp Mol Med 2001; 33: 95-102.
35. Lijnen HR, Demeulemeester D, Van Hoef B, Collen D, Maquoi E. Deficiency of tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) impairs nutritionally induced obesity in mice. Thromb Haemost 2003; 89: 249-255.
36. Armstrong LC, Bornstein P. Thrombospondins 1 and 2 function as inhibitors of angiogenesis. Matrix Biol 2003; 22: 63-71.
37. Stetler-Stevenson WG. Matrix metalloproteinases in angiogen-esis: a moving target for therapeutic intervention. J Clin Invest 1999; 103: 1237-1241.
38. Anand-Apte B, Pepper MS, Voest E, Montesano R, Olsen B, Murphy G et al. Inhibition of angiogenesis by tissue inhibitor of metalloproteinase-3. Invest Ophthalmol Vis Sci 1997; 38: 817-823.
39. Hiraoka N, Allen E, Apel IJ, Gyetko MR, Weiss SJ. Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins. Cell 1998; 95: 365-377.
40. Johnson MD, Kim HR, Chesler L, Tsao-Wu G, Bouck N, Polverini PJ. Inhibition of angiogenesis by tissue inhibitor of metalloproteinase. J Cell Physiol 1994; 160: 194-202.
41. Itoh T, Tanioka M, Yoshida H, Yoshioka T, Nishimoto H. Itohara SReduced angiogenesis and tumor progression in gelatinase A-deficient mice. Cancer Res 1998; 58: 1048-1051.
42. O'Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses M et al. a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 1994; 79: 315-328.
43. O'Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 1997; 88: 277-285.
44. Croissandeau G, Chrétien M, Mbikay M. Involvement of matrix metalloproteinases in the adipose conversion of 3T3-L1 preadi-pocytes. Biochem J 2002; 364: 739-746.
45. Demeulemeester D, Collen D, Lijnen HR. Effect of matrix metalloproteinase inhibition on adipose tissue development. Biochem Biophys Res Commun 2005; 329: 105-110.
46. Okuno A, Tamemoto H, Tobe K, Ueki K, Mori Y, Iwamoto K et al. Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats. J Clin Invest 1998; 101: 1354-1361.
47. de Souza CJ, Eckhardt M, Gagen K, Dong M, Chen W, Laurent D et al. Effects of pioglitazone on adipose tissue remodeling within the setting of obesity and insulin resistance. Diabetes 2001; 50: 1863-1871.
48. Kissebah AH. Central obesity: measurement and metabolic effects. Diabetes Rev 1997; 5: 8-20.